580 related articles for article (PubMed ID: 27404979)
1. T cell recall response of two hypothetical proteins (Rv2251 and Rv2721c) from Mycobacterium tuberculosis in healthy household contacts of TB - Possible subunit vaccine candidates.
Santhi D; Raja A
J Infect; 2016 Nov; 73(5):455-467. PubMed ID: 27404979
[TBL] [Abstract][Full Text] [Related]
2. Dihydrolipoamide dehydrogenase-Lpd (Rv0462)-specific T cell recall responses are higher in healthy household contacts of TB: a novel immunodominant antigen from
Devasundaram S; Raja A
J Leukoc Biol; 2017 Jul; 102(1):135-151. PubMed ID: 28428201
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of antigen-specific memory and regulatory T-cell subsets differentiate latent and active tuberculosis.
Pathakumari B; Devasundaram S; Raja A
Immunology; 2018 Mar; 153(3):325-336. PubMed ID: 28881482
[TBL] [Abstract][Full Text] [Related]
4. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
[TBL] [Abstract][Full Text] [Related]
5. A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates.
Rodo MJ; Rozot V; Nemes E; Dintwe O; Hatherill M; Little F; Scriba TJ
PLoS Pathog; 2019 Mar; 15(3):e1007643. PubMed ID: 30830940
[TBL] [Abstract][Full Text] [Related]
6. Rv2204c, Rv0753c and Rv0009 antigens specific T cell responses in latent and active TB - a flow cytometry-based analysis.
Pathakumari B; Devasundaram S; Maddineni P; Raja A
Int J Med Microbiol; 2018 Mar; 308(2):297-305. PubMed ID: 29325881
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycaemia is inversely correlated with live M. bovis BCG-specific CD4
Boillat-Blanco N; Tumbo AN; Perreau M; Amelio P; Ramaiya KL; Mganga M; Schindler C; Gagneux S; Reither K; Probst-Hensch N; Pantaleo G; Daubenberger C; Portevin D
Immun Inflamm Dis; 2018 Jun; 6(2):345-353. PubMed ID: 29642283
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of late stage specific peptide antigens of Mycobacterium tuberculosis.
Singh M; Bhatt P; Sharma M; Varma-Basil M; Chaudhry A; Sharma S
Infect Genet Evol; 2019 Oct; 74():103930. PubMed ID: 31228643
[TBL] [Abstract][Full Text] [Related]
9. Cell-Mediated Immune Responses to
Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
Front Immunol; 2020; 11():103. PubMed ID: 32117257
[TBL] [Abstract][Full Text] [Related]
10. IFN-γ/TNF-α ratio in response to immuno proteomically identified human T-cell antigens of Mycobacterium tuberculosis - The most suitable surrogate biomarker for latent TB infection.
Prabhavathi M; Pathakumari B; Raja A
J Infect; 2015 Aug; 71(2):238-49. PubMed ID: 25936741
[TBL] [Abstract][Full Text] [Related]
11. Response of IFN-gamma and IgG to ESAT-6 and 38 kDa recombinant proteins and their peptides from Mycobacterium tuberculosis in tuberculosis patients and asymptomatic household contacts may indicate possible early-stage infection in the latter.
López-Vidal Y; de León-Rosales SP; Castañón-Arreola M; Rangel-Frausto MS; Meléndez-Herrada E; Sada-Díaz E
Arch Med Res; 2004; 35(4):308-17. PubMed ID: 15325505
[TBL] [Abstract][Full Text] [Related]
12. PpiA antigen specific immune response is a potential biomarker for latent tuberculosis infection.
Pathakumari B; Anbarasu D; Parthasarathy RT; Raja A
Tuberculosis (Edinb); 2015 Dec; 95(6):736-743. PubMed ID: 26546406
[TBL] [Abstract][Full Text] [Related]
13. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
Coppola M; Ottenhoff TH
Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
[TBL] [Abstract][Full Text] [Related]
14. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
[TBL] [Abstract][Full Text] [Related]
15. A Multistage Subunit Vaccine Effectively Protects Mice Against Primary Progressive Tuberculosis, Latency and Reactivation.
Ma J; Teng X; Wang X; Fan X; Wu Y; Tian M; Zhou Z; Li L
EBioMedicine; 2017 Aug; 22():143-154. PubMed ID: 28711483
[TBL] [Abstract][Full Text] [Related]
16. Enhanced IFN-γ, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART.
Desalegn G; Tsegaye A; Gebreegziabiher D; Aseffa A; Howe R
BMC Immunol; 2019 Oct; 20(1):35. PubMed ID: 31601184
[TBL] [Abstract][Full Text] [Related]
17. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
[TBL] [Abstract][Full Text] [Related]
18. Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis.
Singh S; Saraav I; Sharma S
Vaccine; 2014 Feb; 32(6):712-6. PubMed ID: 24300592
[TBL] [Abstract][Full Text] [Related]
19. Ag85b/ESAT6-CFP10 adjuvanted with aluminum/poly-IC effectively protects guinea pigs from latent mycobacterium tuberculosis infection.
Wang C; Lu J; Du W; Wang G; Li X; Shen X; Su C; Yang L; Chen B; Wang J; Xu M
Vaccine; 2019 Jul; 37(32):4477-4484. PubMed ID: 31266673
[TBL] [Abstract][Full Text] [Related]
20. In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis.
Al-Attiyah R; Mustafa AS; Abal AT; El-Shamy AS; Dalemans W; Skeiky YA
Clin Exp Immunol; 2004 Oct; 138(1):139-44. PubMed ID: 15373916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
